Clinical Characteristics and Outcomes for Patients with Thymic Carcinoma: Evaluation of Masaoka Staging

Por Litvak, Anya M., Woo, Kaitlin, Hayes, Sara, Huang, James, Rimner, Andreas, Sima, Camelia S., Moreira, Andre L., Tsukazan, Maria, Riely, Gregory J.
Publicado no J Thorac Oncol (2014)

Phase I Trial of Cediranib in combination with cisplatin and pemetrexed in chemo naive patients with unresectable malignant pleural mesothelioma (SWOG S0905)

Por Tsao, Anne S., Moon, James, Wistuba, Ignacio I., Vogelzang, Nicholas J., Kalemkerian, Gregory P., Redman, Mary W., Gandara, David R., Kelly, Karen
Publicado no J Thorac Oncol (2017)

Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B trial 9430

Por Stinchcombe, Thomas E., Mauer, Ann M., Hodgson, Lydia D., Herndon, James E., Lynch, Thomas J., Green, Mark. R., Vokes, Everett E.
Publicado em 2008

Clinician Perceptions of Care Difficulty, Quality of Life, and Symptom Reports for Lung Cancer Patients: An Analysis from ECOG E2Z02 (Symptom Outcomes and Practice Patterns; SOAPP)

Por Hamann, Heidi A., Lee, Ju-Whei, Schiller, Joan H., Horn, Leora, Wagner, Lynne I., Chang, Victor Tsu-Shih, Fisch, Michael J.
Publicado em 2013

Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter and Tumor Budding Are Independent Prognostic Factors for Worse Outcomes

Por Kadota, Kyuichi, Nitadori, Jun-ichi, Woo, Kaitlin M., Sima, Camelia S., Finley, David J., Rusch, Valerie W., Adusumilli, Prasad S., Travis, William D.
Publicado no J Thorac Oncol (2014)

Comparative Effectiveness of Adjunctive Bevacizumab for Advanced Lung Cancer: The Cancer Research Network Experience

Por Ritzwoller, Debra P., Carroll, Nikki M., Delate, Thomas, Hornbrook, Mark C., Kushi, Lawrence, Aiello Bowles, Erin J., Loggers, Elizabeth T., Menter, Alex
Publicado no J Thorac Oncol (2014)

A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602)

Por Miller, Antonius A., Pang, Herbert, Hodgson, Lydia, Ramnath, Nithya, Otterson, Gregory A., Kelley, Michael J., Kratzke, Robert A., Vokes, Everett E.
Publicado em 2010

Epidermal Growth Factor Receptor, C-kit, and Her2/neu Immunostaining in Advanced or Recurrent Thymic Epithelial Neoplasms Staged According to the 2004 World Health Organization in Patients Treated with Octreotide and Prednisone: An Eastern Cooperative Oncology Group Study

Por Aisner, Seena C., Dahlberg, Suzanne, Hameed, Meera R., Ettinger, David S., Schiller, Joan H., Johnson, David H., Aisner, Joseph, Loehrer, Patrick J.
Publicado em 2010

Predicting Radiation Pneumonitis After Stereotactic Ablative Radiation Therapy in Patients Previously Treated With Conventional Thoracic Radiation Therapy

Por Liu, Hui, Zhang, Xu, Vinogradskiy, Yevgeniy Y., Swisher, Stephen G., Komaki, Ritsuko, Chang, Joe Y.
Publicado em 2012

A Pilot Study of Chemoradiotherapy With Weekly Docetaxel for Thoracic Esophageal Carcinoma With T4 and/or M1 Lymph Node Metastasis

Por Makino, Isamu, Ninomiya, Itasu, Okamoto, Koichi, Kinoshita, Jun, Hayashi, Hironori, Nakamura, Keishi, Oyama, Katsunobu, Nakagawara, Hisatoshi, Fujita, Hideto, Tajima, Hidehiro, Takamura, Hiroyuki, Kitagawa, Hirohisa, Fushida, Sachio, Tani, Takashi, Fujimura, Takashi, Ohta, Tetsuo, Takanaka, Tsuyoshi
Publicado no World J Oncol (2011)

Reirradiation for Locoregionally Recurrent Lung Cancer Outcomes in Small Cell and Non–Small Cell Lung Carcinoma

Por Kruser, Tim J., McCabe, Bradley P., Mehta, Minesh P., Khuntia, Deepak, Campbell, Toby C., Geye, Heather M., Cannon, George M.
Publicado no Am J Clin Oncol (2014)

P07.01 18F-fluordesoxyglucose positron emission tomography (FDG-PET) for the detection of the primary lesion in brain metastasis (BM) patients with cancer of unknown primary site (...

Por Wolpert, F., Leske, H., Berghoff, A. S., Rushing, E. J., Andratschke, N., Regli, L., Stupp, R., Kaufmann, P., Preusser, M., Weller, M.
Publicado no Neuro Oncol (2016)

Complex-disease networks of trait-associated single-nucleotide polymorphisms (SNPs) unveiled by information theory

Por Li, Haiquan, Lee, Younghee, Chen, James L, Rebman, Ellen, Li, Jianrong, Lussier, Yves A
Publicado em 2012

Clinician Perspectives on Current Issues in Lung Cancer Drug Development

Por Waqar, Saiama N., Bonomi, Philip D., Govindan, Ramaswamy, Hirsch, Fred R., Riely, Gregory J., Papadimitrakopoulou, Vassiliki, Kazandjian, Dickran, Khozin, Sean, Larkins, Erin, Dickson, Dane J., Malik, Shakun, Horn, Leora, Ferris, Andrea, Shaw, Alice T., Jänne, Pasi A., Mok, Tony S.K., Herbst, Roy, Keegan, Patricia, Pazdur, Richard, Blumenthal, Gideon M.
Publicado no J Thorac Oncol (2016)

Biological Pathway-Based Genome-Wide Association Analysis Identified the Vasoactive Intestinal Peptide (VIP) Pathway Important for Obesity

Por Liu, Yong-Jun, Guo, Yan-Fang, Zhang, Li-Shu, Pei, Yu-Fang, Yu, Na, Yu, Ping, Papasian, Christopher J, Deng, Hong-Wen
Publicado em 2010

Exhaled Breath Analysis with a Colorimetric Sensor Array for the Identification and Characterization of Lung Cancer

Por Mazzone, Peter J, Wang, Xiao-Feng, Xu, Yaomin, Mekhail, Tarek, Beukemann, Mary C, Na, Jie, Kemling, Jonathan W, Suslick, Kenneth S, Sasidhar, Madhu
Publicado em 2012

Correlation of Regional Emphysema and Lung Cancer: A Lung Tissue Research Consortium Based Study

Por Hohberger, Laurie A., Schroeder, Darrell R., Bartholmai, Brian J., Yang, Ping, Wendt, Christine H., Bitterman, Peter B., Larsson, Ola, Limper, Andrew H
Publicado em 2014

Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer

Por Speicher, Paul J, Ganapathi, Asvin M, Englum, Brian R, Hartwig, Matthew G, Onaitis, Mark W, D’Amico, Thomas A, Berry, Mark F
Publicado em 2014

Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study

Por Gould, Michael K., Schultz, Ellen M., Wagner, Todd H., Xu, Xiangyan, Ghaus, Sharfun J., Wallace, Robert B., Provenzale, Dawn, Au, David H.
Publicado em 2011

Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer

Por Gadgeel, Shirish M., Wozniak, Antoinette, Ruckdeschel, John C., Heilbrun, Lance K., Venkatramanamoorthy, Raghu, Chaplen, Ruth A., Kraut, Michael J., Kalemkerian, Gregory P.
Publicado em 2008